McClenaghan C, Mukadam M, Roeglin J, Tryon R, Grabner M, Dayal A
EMBO Mol Med. 2023; 15(6):e16883.
PMID: 37154692
PMC: 10245035.
DOI: 10.15252/emmm.202216883.
Petrecca K, Shrier A
J Anat. 1998; 192 ( Pt 4):517-28.
PMID: 9723979
PMC: 1467806.
DOI: 10.1046/j.1469-7580.1998.19240517.x.
Stark G, Sterz F, Stark U, Bachernegg M, Decrinis M, Lueger A
Basic Res Cardiol. 1993; 88(1):23-32.
PMID: 8471001
DOI: 10.1007/BF00788527.
Belardinelli L, Mattos E, BERNE R
J Clin Invest. 1981; 68(1):195-205.
PMID: 7251860
PMC: 370787.
DOI: 10.1172/jci110235.
Motomura S, Taira N
Naunyn Schmiedebergs Arch Pharmacol. 1981; 315(3):241-8.
PMID: 7219573
DOI: 10.1007/BF00499841.
Electrophysiological effects of the salicylates on isolated atrial muscle of the rabbit.
Riccioppo Neto F
Br J Pharmacol. 1982; 77(2):285-92.
PMID: 7139189
PMC: 2044608.
DOI: 10.1111/j.1476-5381.1982.tb09297.x.
Role of calcium antagonists in cardiovascular therapy.
Dargie H, Rowland E, Krikler D
Br Heart J. 1981; 46(1):8-16.
PMID: 7023517
PMC: 482595.
DOI: 10.1136/hrt.46.1.8.
Antihypertensive and renal effects of orally administered verapamil.
Leonetti G, Sala C, Bianchini C, Terzoli L, Zanchetti A
Eur J Clin Pharmacol. 1980; 18(5):375-82.
PMID: 7002568
DOI: 10.1007/BF00636788.
Studies on the bradycardia induced by bepridil.
Beaughard M, Ferrier M, Labrid C, Lamar J, Leboeuf J, Piris P
Br J Pharmacol. 1982; 75(2):293-300.
PMID: 6985297
PMC: 2071601.
DOI: 10.1111/j.1476-5381.1982.tb08785.x.
Calcium and calciferol antagonise effect of verapamil in atrial fibrillation.
Bar-Or D, Gasiel Y
Br Med J (Clin Res Ed). 1981; 282(6276):1585-6.
PMID: 6786574
PMC: 1505570.
DOI: 10.1136/bmj.282.6276.1585-a.
Effects of cyproheptadine on electrophysiological properties of isolated cardiac muscle of dogs and rabbits.
Riccioppo Neto F
Br J Pharmacol. 1983; 80(2):335-41.
PMID: 6652381
PMC: 2045038.
DOI: 10.1111/j.1476-5381.1983.tb10038.x.
Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles.
Anno T, Furuta T, Itho M, Kodama I, TOYAMA J, Yamada K
Br J Pharmacol. 1984; 81(4):589-97.
PMID: 6609738
PMC: 1986901.
DOI: 10.1111/j.1476-5381.1984.tb16123.x.
Electromechanical effects of bepridil on rabbit isolated hearts.
Anno T, Furuta T, Itoh M, Kodama I, TOYAMA J, Yamada K
Br J Pharmacol. 1984; 81(1):41-7.
PMID: 6608388
PMC: 1986954.
DOI: 10.1111/j.1476-5381.1984.tb10741.x.
Calcium antagonists. Clinical use in the treatment of arrhythmias.
Singh B, Nademanee K, Baky S
Drugs. 1983; 25(2):125-53.
PMID: 6339197
DOI: 10.2165/00003495-198325020-00003.
Calcium channel blockers.
Deedwania P
West J Med. 1982; 137(1):24-31.
PMID: 6291255
PMC: 1273979.
Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors.
Pelzer D, TRAUTWEIN W, McDONALD T
Pflugers Arch. 1982; 394(2):97-105.
PMID: 6289260
DOI: 10.1007/BF00582909.
Membrane currents in the rabbit atrioventricular node cell.
Kokubun S, Nishimura M, Noma A, Irisawa H
Pflugers Arch. 1982; 393(1):15-22.
PMID: 6283467
DOI: 10.1007/BF00582385.
The blockade of Vmax of the atrioventricular action potential produced by the slow channel inhibitors verapamil and nifedipine.
KOHLHARDT M, Haap K
Naunyn Schmiedebergs Arch Pharmacol. 1981; 316(2):178-85.
PMID: 6264331
DOI: 10.1007/BF00505314.
The influence of hypoxia and metabolic inhibitors on the excitation process in atrioventricular node.
KOHLHARDT M, Haap K
Basic Res Cardiol. 1980; 75(6):712-27.
PMID: 6260076
DOI: 10.1007/BF01910449.
Calcium antagonists. Pharmacodynamic effects and mechanism of action.
Zsoter T, CHURCH J
Drugs. 1983; 25(2):93-112.
PMID: 6131809
DOI: 10.2165/00003495-198325020-00001.
